SCHEMBL30222931

SCHEMBL30222931

O=CC(CC1CCNC1=O)NC(=O)CCC1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25008065 0.83 NAAA (0.42) —
SCHEMBL30913965 0.81 CCR2 (0.47) —
SCHEMBL30174896 0.81 CTSL (0.45) —
SCHEMBL23721402 0.81 CTSL (0.45) —
SCHEMBL23722564 0.80 — —
SCHEMBL22758567 0.80 — —
SCHEMBL23721439 0.79 — —
SCHEMBL19668601 0.79 CTSL (0.57) —
SCHEMBL19668586 0.79 CTSL (0.57) —
SCHEMBL19668600 0.79 CTSL (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4380920-A1 INHIBITORS FOR CORONAVIRUSES Cocrystal Pharma, Inc. (US) 2024-06-12 — — EP disclosed
WO-2023014758-A1 INHIBITORS FOR CORONAVIRUSES COCRYSTAL PHARMA, INC. (US) 2023-02-09 — — WO disclosed
Send feedback